Marie Wynne cares for her husband, Denis, who has dementia, in their home in
Stillorgan, Co Dublin. Overall, she manages pretty well and pays particular
attention to his medication.
So when
Denis was prescribed anti-psychotic medication last December, she waited until
their adult children had returned to their homes after Christmas to start him
on the medication.
“The doctor
said he was agitated,” she says. “Now, I called it restless but I started him
on the medication anyway.”
Three days
later, while the Wynnes were out with a “Living Well with Dementia” group,
Denis collapsed and was taken by ambulance to St James’s Hospital. Tests at the
hospital could find no reason for the collapse.
Marie Wynne
is convinced that the anti-psychotic medication caused his collapse.
“Denis has
vascular dementia and atrial fibrillation [irregular heartbeat, which can
increase the risk of stroke or heart failure] and I discovered that these
anti-psychotic medications are contra-indicated for that. I also discovered
that they are very powerful drugs that can be of value if someone becomes
violent and aggressive. But Denis wasn’t a suitable candidate.”
She says
Denis has the occasional aggressive outburst, which she’s not surprised about
as when he was younger he was very active: “He played rugby. He was a sales
director in a company. He was always building or making something at home or
working in the garden.” She is concerned that these anti-psychotic medications
are prescribed too quickly for people with dementia who become agitated.
Paddy Sheridan has been the full-time carer of his partner with dementia for five
years. His partner was also prescribed an anti-psychotic medication to help
reduce agitated behaviour.
“I found
that it led to more sleepiness and lack of co-ordination during the day,”
Sheridan says. “So I stopped the daytime tablet and continued with the
night-time one so we could both get a better night’s sleep.”
Jacqueline Keane, whose husband is now in a nursing home, believes that the use of
anti-psychotic medications led to serious deterioration in his condition.
“When my
husband, John, was still at home, he was put on anti-psychotic medication
because he became aggressive sometimes. But when I saw how they impacted on his
ability to walk, talk and feed himself, I took him off this medication.”
However,
when John Keane was taken to hospital, following an episode of extremely
agitated behaviour, he was again prescribed the same anti-psychotic medication.
“I begged
them not to put him back on these drugs,” his wife says. “I know he was
difficult to manage, but again after 1½ days on these drugs, he couldn’t walk,
talk or feed himself again. Yet they continued to give them to him for seven
weeks.”
John was
transferred directly to a nursing home from hospital and “now totally
incapacitated a result of these medications”.
These three
carers are keen to speak out about the use of anti-psychotic medication for
their spouses and partners so that other family carers can become aware of the
potentially negative effects. Marie Wynne, Paddy Sheridan and Jacqueline
Keane also also took part in De-Stress, a study to access the health and
wellbeing of spousal carers of people with dementia in Ireland.
At the June
launch of the study in Trinity College Dublin, one woman spoke about her battle
with medical staff regarding the use of similar anti-psychotic medication for
her husband.
“It was the
most severe aspect of the whole disease. I felt like I was fighting a fog
and a wall of medication, which was isolating my husband more and reducing his
physical capacities as well. There were so many medications that we
fought against, but we felt like we were interfering. The doctors will
admit that none of them are specifically for Alzheimer’s, but they are believed
to keep him safe.”
Sabina Brennan, director of the Neil Memory Research Unit at Trinity and lead
researcher of the De-Stress study, strongly believes that there are
other ways to minimise agitated behaviour other than putting people in chemical
straightjackets. “Giving people with dementia anti-psychotic medication is a
violation of their human rights,” she says.
Brennan
herself had personal experience of the use of these medications when her
mother, who had dementia, was in hospital.
“I used to
ask the medical staff to call me if my mother was confused and walking the
corridors,” she says. “I would go there as soon as I could and calm her down.
But sometimes, the medication had already been administered by the time I’d
arrive.”
At the study
launch, family carers called on the Alzheimer Society of Ireland to campaign against the
use of anti-psychotic drugs for people with dementia.
Tina Leonard, head of advocacy and public affairs at the Alzheimer Society, says the
use of such medications should be a very last resort.
“It is
crucial that local GPs, pharmacists and medical professionals regularly consult
with people with dementia and their family members and carers over any medical
treatment for their loved ones,” Leonard says. “We would encourage any family
member and carers who are concerned over medical treatments for their loved
ones to voice their concerns immediately.”
Adds Ann Twomey, the Alzheimer Society’s advocate for
carers: “You are in charge of their medications. It’s very important for the
carer to inform healthcare professionals about the tablets that agree with
their spouse and the ones that don’t. It’s a good idea to keep a log of
medications and show this to the doctors.”
Prof Brian
Lawlor, old-age psychiatrist at St James’s Hospital in Dublin: believes there
is inappropriate and excessive usage of anti-psychotic medications for patients
with dementia in nursing homes and acute hospitals
Dr Shaun
O’Keeffe, a consultant geriatrician at University Hospital Galway, has spoken
out about the “unnecessary use of potentially hazardous anti-psychotic drugs”
in nursing homes.
Treatment of
dementia patients with anti-psychotic medication over a three-month period can
lead to death in one in 100 cases, according to O’Keeffe. “One in 60
people will have a stroke if regularly prescribed these drugs. Chemical
restraint and the misuse of psychoactive drugs is a violation of personal and
bodily integrity and a breach of article three of the European Convention on
Human Rights.”
To further
complicate the picture, many anti-psychotic medications are not licensed for
use with people with dementia but are still administered. “They are
unfortunately being used a first rather than a last resort in too many cases –
particularly in hospitals which don’t have specialists in dementia care,” adds
O’Keeffe.
Prof Brian Lawlor, old-age psychiatrist at St James’s
Hospital in Dublin, agrees that the use of anti-psychotic medication for people
with dementia is widespread and needs to be curbed, although he says the
medication is beneficial for a small proportion of patients with dementia who
might harm themselves or others.
“The message
is to start low [dose] and go slow and review the medication every four to six
weeks,” he says. “If there are side effects such as problems with sedation,
swallow and mobility, then the person should be taken off it.”
Lawlor
believes there continues to be inappropriate and excessive use of
anti-psychotic medications for patients with dementia in nursing homes and
acute hospitals.
“It’s a
question of education and training,” he says. “Sometimes a person with dementia
can be in pain or distressed about being in a strange environment and he/she
isn’t able to verbalise what’s wrong. Even for cases of delirium, the
cause can be an infection, pain or constipation.”
Studies find
that hospital staff were often focused on the acute medical or surgical reason
that led to hospitalisation of the person, rather than the overall care of the
person with dementia.
Most
healthcare professionals agree that dementia awareness training would go some
way to dealing with overuse of anti-psychotic medication for people with
dementia who seem agitated. And if everyone was more aware of looking
after the basic needs of a person with dementia first, perhaps the medical
profession wouldn’t be so quick as to prescribe anti-psychotic medication.
A wider
focus on the ongoing care of people with dementia can reduce the use of
anti-psychotic medication prescribed for agitated behaviour. And the active
engagement of carers of people with dementia in their hospital care is
extremely important, according to the Irish National Audit of Dementia, which
was published in 2014.
Firstly,
medical staff are often more focused on the acute medical or surgical reason
that led to hospitalisation rather than the overall care of the person with
dementia. Secondly, people with dementia can experience difficulty having
their needs understood and met in acute hospitals, so a family member is often
more familiar with their personal needs.
Dementia
awareness training for all hospital staff is also considered to be crucial for
the holistic care of patients with dementia.
“Three years
ago we introduced dementia awareness training for everyone from porters to
doctors and nurses,” says Prof Brian Lawlor of St James’s Hospital. “There is
still a need for more education and training to manage and support people with
dementia. We need to be able to put ourselves in their shoes and have an
empathic understanding of what is going on for them.”
Specific
training for care attendants would also help ensure the needs of people with
dementia are not neglected in the busy environment of an acute hospital.
In the
absence of family members, care attendants can also ensure patients with
dementia are kept away from chaotic or stressful zones and check that their
basic needs for food, water, going to the toilet and pain relief are always
considered before, during and after receiving treatment.
SOURCE: The Irish Times, Sylvia Thompson